Central Radiopharmaceutical Services

Central Radiopharmaceutical Services (CRS) was a specialized healthcare service provider focused on the preparation and distribution of radiopharmaceuticals for nuclear medicine. The company operated a network of nuclear pharmacies, primarily in the Midwestern United States, providing hospitals and clinics with ready-to-use diagnostic and therapeutic agents. CRS played a critical role in the supply chain for molecular imaging, handling isotopes used in oncology, cardiology, and neurology. In 2004, the company was acquired by Cardinal Health, a move that significantly expanded Cardinal's Nuclear Pharmacy Services division. Following the acquisition, CRS's facilities and expertise were integrated into Cardinal Health's national network, which remains a leader in the radiopharmaceutical industry.